ALEC - Alector Inc. Uzoq muddatli majburiyatlarning kapitalga nisbati
Alector, Inc. (ALEC) Altsgeymer kasalligiga qarshi kurashish uchun sanoat gigantlari bilan global ittifoqlar orqali neyrofarmatsevtika vositalarini rivojlantirmoqda. Ushbu narxlar grafigi aktivning bozor tendentsiyasini aks ettiradi, bunda uzoq muddatli qarzdorlikning kapitalga nisbati 0.00 darajasida turibdi. Brend demensiyaga qarshi miya immunitetini qayta dasturlash usullarini joriy qilmoqda, strategik hamkorlik aloqalari esa mahsulotlar sotuvga chiqquniga qadar boshqa bozor ishtirokchilari tomonidan ko'rsatilayotgan bosimni vaqtincha neytrallashtirmoqda.
%3A%20Uzoq%20muddatli%20qarzning%20o'z%20kapitaliga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_ALEC_-_Alector-Inc._-_Long-Term-Debt-to-Equity-Ratio "ALEC: Alector Therapeutics Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 28.10.2026 | 👁️GURU.Markets👁️")
Alector Inc. (ALEC) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning kapitalga nisbati Alector, Inc.|ALEC - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Alector Therapeutics|ALEC - Kompaniya qarzlari|Qarzning balans kapitallashuviga nisbati Alector, Inc.|ALEC - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Alector
Kompaniyaning har tomonlama tahlili:ALEC, alector.com
Alector, Inc. (ALEC) moliyaviy barqarorligini baholash uzoq muddatli qarzdorlikning kapitalga nisbati asosida amalga oshiriladi, bu esa kompaniyaning uzoq muddatli rejalashtirishda tashqi qarz moliyalashtirishga qanchalik bog'liqlik darajasini belgilaydi. Uzoq muddatli qarzdorlikning kapitalga nisbati tendentsiyasini tahlil qilish orqali investor moliyaviy lift va avtonomiya o'rtasidagi muvozanatni kuzatishi mumkin, bu esa immunonevrologiya va hujayralarni dasturlashdagi qimmatbaho ishlanmalarni qo'llab-quvvatlash uchun juda muhimdir.
Alector, Inc. kimlar bilan raqobatlashadi
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Biogen Inc|Neurocrine Biosciences Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Regencell Corp RGC|Uzoq muddatli qarzning o'z kapitaliga nisbati AXSM (Axsome Therapeutics)|acadia-pharm.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Xenon (XENE)|VKTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati SUPN|Catalyst Corp (CPRX) - Uzoq muddatli majburiyatlarning kapitalga nisbati|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati HRMY|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|Uzoq muddatli qarzning o'z kapitaliga nisbati Amylyx Pharmaceuticals Inc (AMLX)|TRVI: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Praxis Corp PRAX|AVXL: Uzoq muddatli qarzning kapitalga nisbati|ceribell.com (CBLL) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PRTA - Uzoq muddatli qarzning o'z kapitaliga nisbati|ANNX (Annexon Biosciences) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati OMER (Omeros Corp)|Uzoq muddatli majburiyatlarning kapitalga nisbati NGNE|AC Immune (ACIU) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti voyagertherapeutics.com VYGR|Uzoq muddatli qarzning o'z kapitaliga nisbati Neumora Therapeutics, Inc.|Uzoq muddatli qarzning kapitalga koeffitsiyenti Scilex Holding SCLX|Uzoq muddatli qarzning kapitalga nisbati TVGN (Tevogen Bio Holdings, Inc.)|ACOG: Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Cognition Therapeutics|inhibikase.com (IKT) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati SAVA|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Therapeutics (ASRT)|COYA (Coya Therapeutics, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati vistagen.com (VTGN)|Uzoq muddatli qarzning kapitalga nisbati OVID (Ovid Therapeutics)|acumenpharm.com - Uzoq muddatli qarzning kapitalga nisbati|CRVO - Uzoq muddatli qarzning o'z kapitaliga nisbati|ATHE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati CLNN|PepGen (PEPG) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati JUNS|Uzoq muddatli qarzning o'z kapitaliga nisbati RLMD|Uzoq muddatli qarzning o'z kapitaliga nisbati Annovis Bio ANVS|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi gracetx.com (GRCE)|AIFF: Uzoq muddatli qarzning kapitalga nisbati|KLTO - Uzoq muddatli majburiyatlarning kapitalga nisbati|NeuroSense Therapeutics, Ltd. - Uzoq muddatli qarzning o'z kapitaliga nisbati|RVPH: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati metaviatx.com MTVA|NRXS (NeurAxis Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati HSDT (Helius Medical Technologies, Inc.)|Uzoq muddatli majburiyatlarning kapitalga nisbati Passage Bio Corp|Uzoq muddatli qarzning kapitalga nisbati NEUP|Uzoq muddatli qarzning kapitalga nisbati NERV (minervaneurosciences.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati Athira Pharma ATHA|Uzoq muddatli qarzning o'z kapitaliga nisbati Addex Therapeutics Ltd. ADXN|ALZN (Alzamend) - Uzoq muddatli qarzning kapitalga nisbati|CYCN - Uzoq muddatli majburiyatlarning kapitalga nisbati|PTIX (protagenic.com) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pasithea Therapeutics Corp.|Cortigent Inc (CRGT) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati ATXI|Brainstorm Cell Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati CARA (Cara Therapeutics Inc)|Uzoq muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics|ELYM - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Intra-Cellular (ITCI)|LBPH - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Marinus - Uzoq muddatli qarzning kapitalga nisbati|NKGN (NKGen Biotech Corp) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals (NRBO)|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi sagerx.com|Uzoq muddatli qarzning kapitalga nisbati SNPX (Synaptogenix)|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevena Inc. TRVN|Uzoq muddatli qarzning o'z kapitaliga nisbati VIGL|Uzoq muddatli qarzdorlikning kapitalga nisbati Anew Medical Inc. WENA|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati